摘要
目的:分析甲状腺毒症性心脏病的131I治疗前后的心电指标和甲状腺功能水平变化。方法:对160例甲状腺毒症性心脏病患者行血清甲状腺激素FT3、FT4、TSH水平检测和12导联同步心电图检查,分析对比在131I治疗前后的变化。结果:治疗前心电图检查有不同程度的ST-T病理性下降和T波改变,在Ⅱ、Ⅲ导联可出现"不典型的肺型P波"或低振幅的双峰变型P波,P-Q间期延长及Q-T间期延长,FT3、FT4升高TSH降低。在治疗后相关指标多恢复正常,差异有统计学意义(P<0.05)。结论:甲状腺激素水平测定和心电图检测是指导甲状腺毒症性心脏病131I治疗的重要方法。
Objective：To analyze the changes of electrocardiogram and thyroid hormone levels before and after ^131I treatment of thyrotoxie heart disease. Methods： 160 patients with hyperthyroid heart by 12 lead ECG and serum thyroid hormone levels were tested. Results：The differences on the P wave, T wave, ST, P-R, Q-Tc interval, FT3, FT4 and TSH before and after the treatment had statistical significance （ P 〈 0.05 ）. Conclusion： Electrocardiogram Combining with thyroid hormone level is an important method to guide the radionuelide therapy on hyperthyroid heart disease.
出处
《赣南医学院学报》
2014年第1期40-42,共3页
JOURNAL OF GANNAN MEDICAL UNIVERSITY
